Martin R Grubler
Overview
Explore the profile of Martin R Grubler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
982
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Aspelund T, Grubler M, Smith A, Gudmundsson E, Keppel M, Cotch M, et al.
Nutrients
. 2019 Jan;
11(1).
PMID: 30609725
The aim of this study was to determine if increased mortality associated with low levels of serum 25-hydroxyvitamin D (25(OH)D) reflects a causal relationship by using a Mendelian randomisation (MR)...
22.
Richtig G, Hoeller C, Wolf M, Wolf I, Rainer B, Schulter G, et al.
PLoS One
. 2018 Oct;
13(10):e0204729.
PMID: 30273398
Introduction: Immunotherapy is a well-established treatment option in patients with metastatic melanoma. However, biomarkers that can be used to predict a response in these patients have not yet been found,...
23.
Pilz S, Marz W, Cashman K, Kiely M, Whiting S, Holick M, et al.
Front Endocrinol (Lausanne)
. 2018 Aug;
9:373.
PMID: 30065699
Vitamin D deficiency can lead to musculoskeletal diseases such as rickets and osteomalacia, but vitamin D supplementation may also prevent extraskeletal diseases such as respiratory tract infections, asthma exacerbations, pregnancy...
24.
Grubler M, Hunziker L
Crit Care Med
. 2018 Jul;
46(8):e821-e822.
PMID: 30004984
No abstract available.
25.
26.
Swart K, Lips P, Brouwer I, Jorde R, Heymans M, Grimnes G, et al.
Am J Clin Nutr
. 2018 Jun;
107(6):1043-1053.
PMID: 29868916
Background: Evidence from randomized controlled trials (RCTs) for the causal role of vitamin D on noncommunicable disease outcomes is inconclusive. Objective: The aim of this study was to investigate whether...
27.
Pilz S, Trummer C, Verheyen N, Schwetz V, Pandis M, Aberer F, et al.
Horm Metab Res
. 2018 May;
50(5):375-382.
PMID: 29723896
Current guidelines recommend to withdraw mineralocorticoid receptor (MR) blocker treatment for at least 4 weeks when measuring the aldosterone to renin ratio (ARR) as a screening test for primary aldosteronism...
28.
Verheyen N, Grubler M, Catena C, Fahrleitner-Pammer A, van Ballegooijen A
Int J Endocrinol
. 2018 Apr;
2018:9689106.
PMID: 29681938
No abstract available.
29.
Schwetz V, Scharnagl H, Trummer C, Stojakovic T, Pandis M, Grubler M, et al.
J Clin Lipidol
. 2018 Apr;
12(3):588-596.e4.
PMID: 29653812
Background: Vitamin D deficiency is associated with an unfavorable lipid profile, but whether and how vitamin D supplementation affects lipid metabolism is unclear. Objective: To examine the effects of vitamin...
30.
Trummer C, Schwetz V, Pandis M, Grubler M, Verheyen N, Gaksch M, et al.
Eur J Nutr
. 2018 Apr;
58(2):697-703.
PMID: 29602956
Purpose: Fibroblast growth factor-23 (FGF23) is critical for phosphate homeostasis. Considering the high prevalence of vitamin D deficiency and the association of FGF23 with adverse outcomes, we investigated effects of...